Publication Name	World Journal of Clinical Cases
Manuscript ID	87147
Country	China

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma
Manuscript Source	Unsolicited Manuscript
All Author List	Jie Bai, Ying Li and Li Cai
Funding Agency and Grant Number
Corresponding Author	Li Cai, MD, Doctor, Department of Pathology, Huai’an Maternal And Child Health Care Center, No. 104 Renmin South Road, Qingjiangpu District, Huai'an 223002, Jiangsu Province, China. aa14756893@163.com
Key Words	Excellent diagnostic value; Forkhead box M1; Cyclooxygenase-2; Glucose-regulated protein 78; Clinical implications
Core Tip	Forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 exhibit elevated expression in breast invasive ductal carcinoma (BIDC) and are associated with poor prognosis. Their diagnostic value suggests potential as biomarkers for BIDC detection. Understanding their clinical implications can aid in the diagnosis and treatment of BIDC, contributing to improved patient outcomes.
Citation	Bai J, Li Y, Cai L. Clinical implications of forkhead box M1, cyclooxygenase-2, and glucose-regulated protein 78 in breast invasive ductal carcinoma. World J Clin Cases 2023; 11(30): 7284-7293

Received	2023-08-15 10:21
Peer-Review Started	2023-08-15 10:21
To Make the First Decision
Return for Revision	2023-08-31 03:23
Revised	2023-09-11 13:07
Second Decision	2023-09-18 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-09-18 06:50
Articles in Press	2023-09-18 06:50
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-09-22 03:50
Typeset the Manuscript	2023-10-16 01:50

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com